Literature DB >> 31166330

Protective effects of α-galacto-oligosaccharides against a high-fat/western-style diet-induced metabolic abnormalities in mice.

Zhuqing Dai1, Simin Feng, Anna B Liu, Hong Wang, Xiaoxiong Zeng, Chung S Yang.   

Abstract

In this study, we investigated the effects of a newly synthesized α-galacto-oligosaccharide mixture (α-GOSg), 0.5% in drinking water, on high-fat/western-style diet (HFWD)-induced metabolic abnormality in mice in a study of 13 weeks. Raffinose family oligosaccharides (RFOs) were included as a comparison. Mice treated with α-GOSg had significantly lower body weight and body fat (p < 0.05), while RFOs were less effective. Both α-GOSg and RFOs significantly reduced serum levels of total cholesterol and low-density lipoprotein cholesterol, alanine aminotransferase and liver lipids. However, only α-GOSg significantly decreased the histopathological score for liver steatosis and downregulated hepatic fatty acid synthesis gene acetyl CoA carboxylase-α. α-GOSg also significantly reduced the content of bile acids in the small intestine and significantly increased the abundance of gut Bifidobacterium and decreased the abundance of Clostridium leptum. These actions are proposed to be key mechanisms contributing to the beneficial health effects of α-GOSg.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31166330      PMCID: PMC6588291          DOI: 10.1039/c9fo00463g

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  39 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Diets supplemented with chickpea or its main oligosaccharide component raffinose modify faecal microbial composition in healthy adults.

Authors:  W M U Fernando; J E Hill; G A Zello; R T Tyler; W J Dahl; A G Van Kessel
Journal:  Benef Microbes       Date:  2010-06       Impact factor: 4.205

3.  Influence of disaccharide structure on prebiotic selectivity in vitro.

Authors:  María Luz Sanz; Glenn R Gibson; Robert A Rastall
Journal:  J Agric Food Chem       Date:  2005-06-29       Impact factor: 5.279

4.  Microbial ecology: human gut microbes associated with obesity.

Authors:  Ruth E Ley; Peter J Turnbaugh; Samuel Klein; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

6.  Isolation, characterization, and immunological effects of alpha-galacto-oligosaccharides from a new source, the herb Lycopus lucidus Turcz.

Authors:  Xingbin Yang; Yan Zhao; Nianwu He; Kevin D Croft
Journal:  J Agric Food Chem       Date:  2010-07-28       Impact factor: 5.279

Review 7.  Galacto-oligosaccharide production using microbial beta-galactosidase: current state and perspectives.

Authors:  Ah-Reum Park; Deok-Kun Oh
Journal:  Appl Microbiol Biotechnol       Date:  2009-11-27       Impact factor: 4.813

8.  Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice.

Authors:  Chenhong Zhang; Menghui Zhang; Shengyue Wang; Ruijun Han; Youfang Cao; Weiying Hua; Yuejian Mao; Xiaojun Zhang; Xiaoyan Pang; Chaochun Wei; Guoping Zhao; Yan Chen; Liping Zhao
Journal:  ISME J       Date:  2009-10-29       Impact factor: 10.302

9.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

10.  Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1.

Authors:  Chikage Mataki; Benjamin C Magnier; Sander M Houten; Jean-Sébastien Annicotte; Carmen Argmann; Charles Thomas; Henk Overmars; Wim Kulik; Daniel Metzger; Johan Auwerx; Kristina Schoonjans
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

View more
  1 in total

Review 1.  Hypolipidemic Effects of β-Glucans, Mannans, and Fucoidans: Mechanism of Action and Their Prospects for Clinical Application.

Authors:  Tatiana A Korolenko; Nataliya P Bgatova; Marina V Ovsyukova; Alexandra Shintyapina; Vaclav Vetvicka
Journal:  Molecules       Date:  2020-04-16       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.